CAS NO: | 102146-07-6 |
包装 | 价格(元) |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | DPCPX (PD 116948), a xanthine derivative, is a highly potent and selectiveAdenosine A1 receptorantagonist, with aKiof 0.46 nM in3H-CHA binding to A1 receptors in rat whole brain membranes[1][2][3]. | ||||||||||||||||
IC50& Target | Ki: 0.46 nM (3H-CHA binding to A1 receptors in rat whole brain membranes); 340 nM (3H-NECA binding to A2 receptors in rat striatal membranes)[2]. | ||||||||||||||||
体内研究 (In Vivo) | DPCPX (PD 116948) ( 0.1, 0.3 and 1.0 mg/kg i.v. ) produces significant dose-related increases (P<0.05) in urine volume and in urinary sodium, potassium and chloride excretion[3]. | ||||||||||||||||
分子量 | 304.39 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C16H24N4O2 | ||||||||||||||||
CAS 号 | 102146-07-6 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 10 mg/mL(32.85 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在本网站选购。 |